Home NDC 0944-2814 Aralast
Product NDC 0944-2814
11-digit product format 009442814
Labeler code 0944
Product ID 0944-2814_20ede125-2505-4088-8f5e-c6d2d5c7c80a
Type PLASMA DERIVATIVE
Nonproprietary name Alpha-1-Proteinase Inhibitor (Human)
Dosage form KIT
Labeler Takeda Pharmaceuticals America, Inc.
Application BLA125039
Marketing category BLA
Marketing start 2002-12-23
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Aralast
Brand name suffix NP
Listing expiration 2026-12-31
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1233711 Internal RxNorm lookup 1661208 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0944-2803-03 AralastNP 25 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 25 mL 16 mg in 1mL 20 0944-2814-01 AralastNP 1 in 1 CARTON KIT 1 20
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0944-2814 ARALAST NP (ALPHA-1-PROTEINASE INHIBITOR (HUMAN)) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] 18 Current NDC, Legacy NDC, 2 package rows 20241121_a9a5b46e-04da-41bd-bb5f-c4936b664fef.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Aralast NP ALPHA-1-PROTEINASE INHIBITOR (HUMAN) Takeda Pharmaceuticals America, Inc. a9a5b46e-04da-41bd-bb5f-c4936b664fef 2025-11-25 Warnings, Adverse reactions Exact identifier application number: BLA125039 ndc (product): 0944-2814
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125039 Aralast, Aralast Np Alpha-1-Proteinase Inhibitor (Human) 351(a) Rx 2026-10-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0944-2803-03 00944280303 25 mL in 1 VIAL 25 ml Historical 0944-2814-01 00944281401 1 KIT in 1 CARTON (0944-2814-01) * 25 mL in 1 VIAL, GLASS (64764-518-25) * 25 mL in 1 VIAL (0944-2803-03) 1 kit 2002-12-23 0000-00-00 No No Current